Danaher’s Masimo Receives FDA Clearance for OIRD Detection
Masimo, a Danaher company, announced FDA 510(k) clearance for an opioid-induced respiratory depression, OIRD, detection capability integrated into the Radius VSM wearable continuous patient monitor. Enabled by Masimo's next-generation smartSET pulse oximetry sensor platform.
